Skip to main content
. Author manuscript; available in PMC: 2022 Feb 16.
Published in final edited form as: J Am Coll Cardiol. 2021 Feb 16;77(6):713–724. doi: 10.1016/j.jacc.2020.11.066

Figure 3 – Discriminative value of baseline tricuspid annular dilation for TR progression and >=moderate TR after surgery.

Figure 3 –

Tricuspid regurgitation (TR) at 2 years according to tricuspid annular dilation (TAD) at baseline, applying the non-indexed, indexed and combined dilation cut-off respectively. Patients without annular dilation based on the cut-off are displayed in blue, and patients with annular dilation are displayed in orange. The number of patients that had either TR progression (n=20) or ≥moderate TR (n=37) are highlighted in dark colors, whereas the patients without TR progression or <moderate TR are displayed in light colors.